Revvity | 资产

股票价格
95.90
每天变化
0.31 0.32%
每月一次
-7.64%
每年
-12.23%
Q1 预测
95.30


金融业
股票价格
USD
资产
USD 12.17B
现金及等价物
USD 919.86M
销售成本
USD 350.4M
流动资产
USD 2.24B
流动负债
USD 1.33B
债务
USD 3.37B
股息收益率
0.29
EBIT
USD 145.83M
EBITDA
USD 248.91M
员工
11K
EPS每股收益
USD 1.7
股本和储备
USD 7.38B
销售毛利
USD 421.66M
债务利息支出
USD 23.51M
利息收入
USD 0.4
贷款资金
USD 2.63B
市值
USD 11.27B
净收入
USD 98.36M
营业费用
USD 626.22M
营业利润
USD 145.83M
普通股股本
USD 113.38M
PE价格收益
USD 49.87
税前利润
USD 55.68M
销售收入
USD 772.06M
销售和管理费用
USD 251.73M
股票
USD 379.5M
贸易债权人
USD 185.46M
应收帐款人
USD 744.67M


资产 更改 日
Agilent USD 12.81B 86M 2025-12
Align Technology USD 6.23B 141K 2025-12
Bio Techne USD 2.52B 3.45M 2025-12
Bio-Rad Laboratories USD 10.58B 880.1M 2025-12
Bruker USD 6.24B 193.5M 2025-12
Celltrion KRW 21.08T 530.63B 2025-09
Charles River Laboratories USD 7.14B 378.39M 2025-12
Cspc Pharmaceutical CNY 46B 1.61B 2025-06
Danaher USD 83.46B 3.57B 2025-12
Dentsply International USD 5.43B 224M 2025-12
Deva Holding AS TRY 12.93B 1.83B 2023-09
Dianthus Therapeutics USD 577.44M 251.37M 2025-09
Divis Laboratories Ltd INR 181.51B 12.19B 2025-09
Edwards Lifesciences USD 13.27B 216.5M 2025-09
Exact Sciences USD 5.86B 39.38M 2025-12
Hologic USD 9.18B 165.8M 2025-12
Illumina USD 6.64B 467M 2025-12
Intuitive Surgical USD 20.46B 1.11B 2025-12
IQVIA Holdings USD 29.94B 1.22B 2025-12
Kangmei Pharma CNY 13.68B 38.19M 2025-09
Knight Therapeutics CAD 962.29M 16.93M 2024-09
Laboratorios Farma EUR 799.88M 99.95M 2023-12
Laboratory Of America USD 18.39B 131.1M 2025-12
Malin Corporation EUR 198.5M 70.1M 2024-12
Medical Developments International AUD 63.57M 2.83M 2025-12
Mesa Laboratories USD 434.85M 4.5M 2025-12
Mettler Toledo International USD 3.71B 191.18M 2025-12
Myriad Genetics USD 728.1M 50.8M 2025-09
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
OraSure Technologies USD 423.1M 21.94M 2025-09
Organigram Holdings CAD 562.21M 2.4M 2025-09
Ovoca Bio EUR 11.41M 3.36M 2022-06
Pacific Biosciences Of California USD 803.16M 22.31M 2025-09
Pharma Mar EUR 395.08M 53.42M 2025-12
Qiagen NV USD 6.3B 257.54M 2025-12
Quest Diagnostics USD 16.23B 28M 2025-12
Quidel USD 5.77B 94.2M 2025-12
Repligen USD 2.95B 25.99M 2025-12
Revvity USD 12.17B 29.46M 2025-12
Sartorius EUR 9.61B 413.4M 2025-09
Sino Biopharmaceutical CNY 74.89B 9.49B 2025-06
Thermo Fisher Scientific USD 110.34B 7.32B 2025-12
Tilray USD 2.07B 1.33B 2025-03
Waters USD 5.08B 221.41M 2025-12
Zz Pientze Pharmaceu CNY 17.48B 1.23B 2025-09


Revvity 资产 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2026.